Search results
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 2 days agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 hours agoProgression-free survival is how long patients live before their cancer worsens. The company added...
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe Sweden-headquartered company presented the Phase II readout at the American...confirmed...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 5 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 3 days agoIn the MCL cohort of the TRANSCEND NHL 001 trial...received two to four prior lines of therapy....
Scientists and Indigenous leaders team up to conserve seals and an ancestral way of life at Yakutat,...
The Conversation via Yahoo News· 4 hours agoCollaborative research by archaeologists, environmental scientists and tribal elders combines...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 5 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
The Woonsocket Call· 6 days agoEMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival ...
Think about planting a meadowscape in place of some grass
The Monroe Evening News· 3 days agoAs of May 29, and since April 1, the MSU Enviroweather site at Deerfield has received almost double...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 days agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...